Premium
Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C – authors’ reply
Author(s) -
Hu C.C.,
Chien R.N.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12189
Subject(s) - medicine , ribavirin , cirrhosis , pegylated interferon , hepatocellular carcinoma , gastroenterology , hepatitis c virus , adverse effect , chronic hepatitis , hepatitis c , immunology , virus